Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Frontiers in Oncology
|
October 22, 2021
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation
Wenxiu Zhao, Lingxiang Jiang, Ting Fang, et al.
Antioxidants & Redox Signaling
|
November 9, 2017
Modulators of Redox Metabolism in Head and Neck Cancer
Xiaofei Chen, Jade Mims, Xiumei Huang, et al.
Oncoimmunology
|
June 7, 2024
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
Soumya Tumbath, Lingxiang Jiang, Xiaoguang Li, et al.
Scientific Reports
|
January 7, 2016
RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits
Li Yan, Yaomin Chen, Wubo Li, et al.
Antioxidants & Redox Signaling
|
November 11, 2023
Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill <i>NQO1</i>-Positive Pancreatic Cancer Cells
Lingxiang Jiang, Yingchun Liu, Soumya Tumbath, et al.
Cancers
|
December 23, 2023
Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms
Jiangwei Wang, Xiaolin Su, Lingxiang Jiang, et al.
Frontiers in Oncology
|
October 7, 2022
KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib <i>via</i> Inhibiting FOXO3a/GADD45α Pathway
Lingxiang Jiang, Yingchun Liu, Xiaolin Su, et al.
Journal of Surgical Oncology
|
March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
Cancer Research
|
April 26, 2012
An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis
Xiumei Huang, Ying Dong, Erik A Bey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 2, 2012
Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration
Han Zhang, Yun-wu Zhang, Yaomin Chen, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Frontiers in Oncology
|
October 22, 2021
β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation
Wenxiu Zhao, Lingxiang Jiang, Ting Fang, et al.
Antioxidants & Redox Signaling
|
November 9, 2017
Modulators of Redox Metabolism in Head and Neck Cancer
Xiaofei Chen, Jade Mims, Xiumei Huang, et al.
Oncoimmunology
|
June 7, 2024
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
Soumya Tumbath, Lingxiang Jiang, Xiaoguang Li, et al.
Scientific Reports
|
January 7, 2016
RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits
Li Yan, Yaomin Chen, Wubo Li, et al.
Antioxidants & Redox Signaling
|
November 11, 2023
Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill <i>NQO1</i>-Positive Pancreatic Cancer Cells
Lingxiang Jiang, Yingchun Liu, Soumya Tumbath, et al.
Cancers
|
December 23, 2023
Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms
Jiangwei Wang, Xiaolin Su, Lingxiang Jiang, et al.
Frontiers in Oncology
|
October 7, 2022
KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib <i>via</i> Inhibiting FOXO3a/GADD45α Pathway
Lingxiang Jiang, Yingchun Liu, Xiaolin Su, et al.
Journal of Surgical Oncology
|
March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
Cancer Research
|
April 26, 2012
An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis
Xiumei Huang, Ying Dong, Erik A Bey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 2, 2012
Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration
Han Zhang, Yun-wu Zhang, Yaomin Chen, et al.
Page
of 7